Title
Consider recommendations regarding Waivers of Competition under County Code Section 2-39 for the purchase of pharmaceuticals for the 340B Contract Pharmacy Network Program, as follows:
a) Authorize the Purchasing Manager to procure pharmaceuticals for the 340B Contract Pharmacy Network Program from AmerisourceBergen Drug Company (not a local vendor) without requiring competitive bidding since Contract Pharmacies and Amerisource Bergen Drug Company maintain exclusivity agreements, and to ensure 340B Program compliance for an amount up to but not to exceed $3,100,000.00 per year and an aggregate costs not to exceed $9,300,000.00 for the period July 1, 2018 through June 30, 2021;
b) Authorize the Purchasing Manager to procure pharmaceuticals for the 340B Contract Pharmacy Network Program from Cardinal Health (not a local vendor) without requiring competitive bidding since Contract Pharmacies and Cardinal Health maintain exclusivity agreements, and to ensure 340B Program compliance for an amount up to but not to exceed $2,500,000.00 per year and aggregate costs not to exceed $7,500,000.00 for the period July 1, 2018 through June 30, 2021;
c) Authorize the Purchasing Manager to procure pharmaceuticals for the 340B Contract Pharmacy Network Program from McKesson (not a local vendor) without requiring competitive bidding since Contract Pharmacies and McKesson maintain exclusivity agreements, and to ensure 340B Program compliance for an amount up to but not to exceed $200,000.00 per year and aggregate costs not to exceed $600,000.00 for the period July 1, 2018 through June 30, 2021;
d) Authorize the Purchasing Manager to amend purchasing contract BL14003 with McKesson to increase the amount from $150,000.00 to $180,000.00 for Fiscal Year 2017-2018 for the 340B Contract Pharmacy Network Program;
e) Approve and authorize the Director of the Public Health Department to execute or terminate Agreements with local 340B Contract Pharmacies to ensure sustainability ...
Click here for full text